BNP/CALL/EDWARDS LIFESCIENCES/105/0.1/17.01.25 | Real-time Bid/Ask 07:23:56 2024-06-24 EDT | ||
| 0.39 EUR / 0.46 EUR | +28.79% |
|
| Current month | +10.00% | ||
| 1 month | -8.33% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-24 | 0.38 | +15.15% |
| 24-06-21 | 0.33 | 0.00% |
| 24-06-20 | 0.33 | +3.13% |
| 24-06-19 | 0.32 | +14.29% |
| 24-06-18 | 0.28 | 0.00% |
Delayed Quote Börse Stuttgart
Last update June 24, 2024 at 02:29 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PC6NNB |
| ISIN | DE000PC6NNB9 |
| Date issued | 2024-03-14 |
| Strike | 105 $ |
| Maturity | 2025-01-17 (208 Days) |
| Parity | 10 : 1 |
| Emission price | 0.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.79 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.07 € |
| Spread % | 15.22% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.9
USD
Average target price
96.05
USD
Spread / Average Target
+5.67%
- Stock Market
- Warrants
- Warrant
